TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 249 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $474 | -80.9% | 56,660 | -43.3% | 0.02% | -79.6% |
Q2 2023 | $2,482 | +351.3% | 99,931 | +173.2% | 0.11% | +315.4% |
Q1 2023 | $550 | -75.1% | 36,580 | -80.4% | 0.03% | -78.9% |
Q4 2022 | $2,213 | -99.7% | 187,029 | +72.7% | 0.12% | +215.4% |
Q3 2022 | $641,000 | +51.2% | 108,309 | +8.7% | 0.04% | +21.9% |
Q2 2022 | $424,000 | -33.2% | 99,670 | +716.4% | 0.03% | -82.3% |
Q4 2020 | $635,000 | – | 12,208 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |